49.23
49.23 (0%)
As of Apr 17, 2025
Bristol Myers Squibb Co [BMY]
Source:
Company Overview
Bristol Myers Squibb Co operate in one segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Our principal strategy is to combine the resources, scale and capability of a pharmaceutical company with the speed and focus on innovation of the biotech industry.
| Country | United States |
| Headquarters | princeton, new jersey |
| Phone Number | (609) 252-4621 |
| Industry | manufacturing |
| CEO | Bristol Myers Squibb Co |
| Website | www.bms.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $48,300 |
| Operating Profit | |
| Net Income | $-8,933 |
| Net Cash | $-1,172 |
Profit Ratios
| Gross Margin | $34,332 |
| Operating Margin | |
| Profit as % of Revenues | -384.3% |
| Profit as % of Assets | -9.5% |
| Profit as % of Stockholder Equity | -54.5% |
Management Effectiveness
| Return on Equity | -54.5% |
| Return on Assets | -9.7% |
| Turnover Ratio | 51.5% |
| EBITA | $8,872 |
Balance Sheet and Cash Flow Measures
| Total Assets | $92,603 |
| Total Liabilities | $76,215 |
| Operating Cash Flow | $15,190 |
| Investing Cash Flow | $-21,352 |
| Financing Cash Flow | $5,127 |
